"Paradigm Clinical Research Centers Inc, are like no other Pharmaceutical Research center you have worked with. Whether you are a patient or a Sponsor, the Dedicated physicians and Quality research staff make the process smooth and safe. Founded in 2009, each of our locations will provide the highest quality data in the industry. All of our locations can preform trials in Phases I – IV."

During the past decade, Paradigm Clinical Research Centers, Inc. conducted 36 clinical trials. In the 10-year time frame, 36 clinical trials started and 15 clinical trials were completed, i.e. on average, 41.7% percent of trials that started reached the finish line to date. In the past 5 years, 24 clinical trials started and 13 clinical trials were completed. i.e. 54.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Paradigm Clinical Research Centers, Inc." #1 sponsor was "Pfizer" with 8 trials, followed by "ModernaTX, Inc." with 5 trials sponsored, "Janssen Vaccines & Prevention B.V." with 4 trials sponsored, "Allergan" with 2 trials sponsored and "Bavarian Nordic" with 2 trials sponsored. Other sponsors include 16 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Paradigm Clinical Research Centers, Inc." #1 collaborator was "Pfizer" with 2 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Syneos Health" with 1 trials as a collaborator and "bioRASI, LLC" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Paradigm Clinical Research Centers, Inc." are "Respiratory Syncytial Virus" (3 trials), "COVID-19" (2 trials), "Clostridium Difficile Associated Disease" (2 trials), "Episodic Migraine" (2 trials) and "Influenza, Human" (2 trials). Many other conditions were trialed in "Paradigm Clinical Research Centers, Inc." in a lesser frequency.

Most popular intervention types in "Paradigm Clinical Research Centers, Inc." are "Drug" (22 trials), "Biological" (21 trials) and "Other" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (29 trials), "mRNA-1345" (3 trials), "Ad26.COV2.S" (2 trials), "Atogepant" (2 trials) and "BNT162b2" (2 trials). Other intervention names were less common.

The vast majority of trials in "Paradigm Clinical Research Centers, Inc." are 40 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Paradigm Clinical Research Centers, Inc.". undefined are not yet recruiting, 9 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Paradigm Clinical Research Centers, Inc., undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Paradigm Clinical Research Centers, Inc., 2 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".